Effect of Hydroxyurea on Mortality and Morbidity in Adult Sickle Cell Anemia

Abstract

Adult patients taking hydroxyurea for frequent painful sickle cell episodes appear to have reduced mortality after 9 of years follow-up. Survival was related to HbF levels and frequency of vaso-occlusive events. Whether indications for hydroxyurea treatment should be expanded is unknown.